• Nenhum resultado encontrado

[PDF] Top 20 Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer

Has 10000 "Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer" found on our website. Below are the top 20 most common "Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer".

Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer

Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer

... RESUMO – Contexto - A capecitabina, uma droga oral, é tão eicaz quanto as drogas quimioterápicas tradicionais. Objetivo - Investigar a adesão ao tratamento oral com capecitabina para câncer de mama e colorretal e ... See full document

6

Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer.

Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer.

... depression and anxiety observed in our study among hospitalized breast cancer patients need to be considered, including one or more diagnostic barriers at the individual, ... See full document

14

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

... accordance with a role for miR-664-3p in ...Interestingly, among the top predicted targets of miR-664-3p are neuroligin 1 (NLGN1), MDGA2, and gephyrin, which are all involved in the same synaptogenic ... See full document

11

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.

... studies. To determine the frequency and prognostic value of EMAST in mCRC patients with MSI tumors we selected 50 mCRC patients with MSI tumors treated in both CAIRO ...the ... See full document

13

Does Knowing Someone with Breast Cancer In fluence the Prevalence of Adherence to Breast

Does Knowing Someone with Breast Cancer In fluence the Prevalence of Adherence to Breast

... with breast cancer can be considered elevated in this ...contribution to whether an individual seeks cancer screen- ...of breast cancer is beneficial, since it would lead ... See full document

6

Sao Paulo Med. J.  vol.124 número4

Sao Paulo Med. J. vol.124 número4

... CONTEXT AND OBJECTIVE: In metastatic breast cancer cases, the currently available therapeutic approaches provide minimal improvement in sur- ...was to evaluate changes in QOL ... See full document

5

Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.

Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.

... higher among patients diagnosed with the first cancer at an early age; the overall risk increase for breast cancer patients compared to the general female ... See full document

8

Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer

Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer

... present study was to investigate the effect of leptin on the progression of colorectal carcinoma to metastatic disease by analyzing the serum leptin concentration and Ob-R ... See full document

5

Rev. LatinoAm. Enfermagem  vol.22 número5

Rev. LatinoAm. Enfermagem vol.22 número5

... Objective: to verify depressive symptoms and adherence to chemotherapy among women with breast cancer who are served by the Pharmacy of the Chemotherapy Center of a ... See full document

8

Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women.

Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women.

... education, and annual household ...level to avoid the necessity of knowing family size and number of ...Nine patients elected not to report annual household ...‘Non-adherence ... See full document

8

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

... elderly patients with newly diagnosed colorectal cancer present with poor PS due to cancer compli- cations or comorbidities ...studies with elderly patients ... See full document

7

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

... plus capecitabine arm, and thrombo- cytopenia and elevated transaminases occurred to a greater extent in the T-DM1 ...ment with T-DM1. Data in patients previously treated ... See full document

5

The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).

The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).

... 863 patients with metastatic disease at either ini- tial diagnosis or recurrence after receiving adjuvant therapy between January 2000 and Decem- ber ...the breast cancer ... See full document

11

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer

... or metastatic breast cancer should also be evaluated, because for metastatic breast cancer with positive hormone receptors ...trastuzumab and lapatinib have also ... See full document

8

Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.

Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.

... Adherence to treatment guidelines could be one of the reasons why high-volume providers have better ...likely to interact with oncologists or attend multi- disciplinary meetings for ... See full document

10

Einstein (São Paulo)  vol.9 número4

Einstein (São Paulo) vol.9 número4

... 86 patients with metastatic colorectal cancer treated with oxaliplatin (85 mg/m² on days 1 and 15 of each 28-day ...cycle). Patients were randomized ... See full document

7

Rev. Assoc. Med. Bras.  vol.49 número4

Rev. Assoc. Med. Bras. vol.49 número4

... 3. Nanda K. Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: a systematic review. Am J Obstet Gynecol 2002; 186:325-34. 4. Bosman A, Kenemans P. ... See full document

1

J. Coloproctol. (Rio J.)  vol.31 número4

J. Coloproctol. (Rio J.) vol.31 número4

... useful to the prognosis of patients with recently diagnosed ...CRC. Patients with serum CEA >5 ng/mL in the pre- operative period have worse prognosis than those with lower ... See full document

5

Rev. Hosp. Clin.  vol.56 número2

Rev. Hosp. Clin. vol.56 número2

... database. To obtain a minimum follow-up of 5 years, the records were reviewed from February 1990 to December 1995, with histologically proven stage IV NSCLC and with no demonstrable ... See full document

6

Challenging metastatic breast cancer with the natural defensin PvD1

Challenging metastatic breast cancer with the natural defensin PvD1

... for breast cancer disease and respective brain metastatic lesions ’ management reside in the need for devel- oping drugs that can recognize cancer cells and accumulate e fficiently ... See full document

13

Show all 10000 documents...